Pharma Capital

Admedus' Wayne Paterson discusses revenue strategy and pathway for CardioCel 3D

Wayne Paterson, chief executive officer for Admedus, speaks with Proactive Investors.

 

View full AHZ profile

Admedus Ltd Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.